Rapid advances in the fields of DNA vaccines and gene therapy 1,2 have produced increased demands for large quantities of recombinant plasmid DNA. The problem is further exacerbated, as efficiency of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback